Next Science Ltd (AU:NXS) has released an update.
Next Science Ltd, an Australian med-tech firm, has announced the release of its 2024 Corporate Governance Statement in line with ASX guidelines. The company, known for its XBIO technology targeting biofilm-based infections, emphasizes transparency and adherence to corporate governance standards. Investors and stakeholders are directed to Next Science’s website for detailed governance information.
For further insights into AU:NXS stock, check out TipRanks’ Stock Analysis page.
